SCHEMBL7529541

SCHEMBL7529541

NCC1C=Cc2ccccc2N1Br

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.40
TSHR P16473 2/20 0.40
MAPK1 P28482 2/20 0.40
ALDH1A1 P00352 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
HTR2A P28223 1/20 0.37
LMNA P02545 3/20 0.35
SCN4A P35499 1/20 0.35
SCN5A Q14524 1/20 0.35
SCN9A Q15858 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
P2RX4 Q99571 4/20 0.32
P2RX1 P51575 3/20 0.32
P2RX3 P56373 3/20 0.32
P2RX7 Q99572 3/20 0.32
GRIN1 Q05586 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31463623 0.85 TSHR (0.36) SMN1; SMN2TSHRMAPK1ALDH1A1NPSR1
SCHEMBL28255971 0.80 SMN1; SMN2 (0.39) SMN1; SMN2TSHRMAPK1ALDH1A1NPSR1
SCHEMBL28228979 0.70 KMT2A (0.37) SMN1; SMN2TSHRMAPK1ALDH1A1NPSR1
SCHEMBL24467797 0.68 MEN1 (0.36) SMN1; SMN2TSHRMAPK1ALDH1A1NPSR1
SCHEMBL5107389 0.67 HTR1A (0.36) HTR2AHTR6
SCHEMBL22694317 0.67 MEN1 (0.37) SMN1; SMN2TSHRMAPK1ALDH1A1NPSR1
SCHEMBL22202241 0.67 SMN1; SMN2 (0.43) SMN1; SMN2TSHRMAPK1ALDH1A1NPSR1
SCHEMBL28886571 0.66 SMN1; SMN2 (0.42) SMN1; SMN2TSHRMAPK1ALDH1A1NPSR1
SCHEMBL3625895 0.66 SMN1; SMN2 (0.39) SMN1; SMN2TSHRMAPK1ALDH1A1NPSR1
SCHEMBL5527248 0.66 ALDH1A1 (0.42) SMN1; SMN2TSHRMAPK1ALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6500953-B1 AMIDATION OF 3-AMINOMETHYL-2-BROMOQUINOLINE DERIVATIVE WITH 4-ETHYL-2-METHYLHEPTA-2,4-DIENOIC ACID; REPLACING BROMINE WITH 2-METHOXYCARBONYLVINYL GROUP; CYCLIZATION, OZONOLYSIS, SAPONIFICATION AND DECARBOXYLATION AVENTIS PHARMA S.A. (FR) 2002-12-31 US disclosed
EP-1100799-B1 PREPARATION OF CAMPTOTHECIN AND NOTHAPODYTINE DERIVATIVES AVENTIS PHARMA SA (FR) 2002-02-13 EP disclosed